1983
DOI: 10.1016/0192-0561(83)90048-6
|View full text |Cite
|
Sign up to set email alerts
|

Effects of immunological adjuvants on the mouse complement system. I. The inability of the polyanion heparin to act as an adjuvant is paralleled by inefficient alternative complement pathway inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
6
0

Year Published

1984
1984
1987
1987

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 20 publications
1
6
0
Order By: Relevance
“…Immunol.]. Both DDA and DXS have been suggested to inhibit various processes involved in antigen elimination by the reticuloendo thelial system [4,5,7,16,17]. The data presented here suggest that the modes of action of the other surfact ants tested are comparable with that of DDA but are distinct from that of DXS.…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…Immunol.]. Both DDA and DXS have been suggested to inhibit various processes involved in antigen elimination by the reticuloendo thelial system [4,5,7,16,17]. The data presented here suggest that the modes of action of the other surfact ants tested are comparable with that of DDA but are distinct from that of DXS.…”
Section: Discussionsupporting
confidence: 60%
“…Combining the syn thetic adjuvants dimethyldioctadecylammonium bro mide (DDA) and dextran sulfate (DXS) resulted in a synergistically enhanced humoral response to sheep red blood cells (SRBC) [14], The synergy is considered to be the consequence of different but complementary mechanisms responsible for the immunostimulating activity of either component. The surfactant DDA and the polyanion DXS differ in physicochemical [14], biological [2,3,7,9,16,17,[20][21][22][24][25][26], and immunostimulating [12 and accompanying paper] properties, and therefore we expected distinct modes of action. Consequently, synergistic stimulatory ac tivities of adjuvants might be expected if the modes of action are distinct.…”
Section: Introductionmentioning
confidence: 99%
“…monocytogenes is an activator of the mouse alternative complement (C) pathway (ACP) (15). The adjuvant activity of polyanions in the listeria model corresponds to their anticomplementary effects on the mouse ACP in vitro (5). These observations suggested that the interaction of polyanions with the C cascade would be involved in their adjuvant effect.…”
mentioning
confidence: 77%
“…1B). This can probably be ascribed to the strong anticomplementary activity of this substance in the ACP assay, as observed in vitro with mouse serum as the C source (5). This explanation is strengthened by the finding that the listeria-induced enhancement of peritoneal C levels was not antagonized by the other polyanion, heparin (Kabi AB, Stockholm, Sweden) ( Fig.…”
mentioning
confidence: 86%
See 1 more Smart Citation